In summary, we show that loss of SETD2 induces marked changes in cellular phenotype independent of other ccRCC mutations and consistent with the greater metastatic propensity of SETD2‐mutant ccRCC. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.